Targeting of Cisplatin-Resistant Melanoma Using a Multivalent Ligand Presenting an Elastin-like Polypeptide-Reference-Cited by-同舟云学术

Targeting of Cisplatin-Resistant Melanoma Using a Multivalent Ligand Presenting an Elastin-like Polypeptide

Published:2020-07-22 Issue:9 Volume:6 Page:5024-5031
ISSN:2373-9878
Container-title:ACS Biomaterials Science & Engineering
language:en
Short-container-title:ACS Biomater. Sci. Eng.

Author:

Cheon Sun-Ha¹,Seo Bo-Yeon¹,Lee Young-Jin¹,Sim Dahye¹,Lee Seon-Boon¹,Guruprasath Padmanaban¹,Singh Thoudam Debraj²,Lee Byung-Heon¹,Sarangthem Vijaya¹³^ORCID,Park Rang-Woon¹^ORCID

Affiliation:

1. Department of Biochemistry and Cell Biology, Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea

2. Department of Medical Oncology Laboratory, All India Institute of Medical Sciences, New Delhi 110029, India

3. Department of Pathology, All India Institute of Medical Sciences, New Delhi 110029, India

Funder

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.0c00599

Reference31 articles.

1. AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment